ArticleFrontiers in oncology2026

Beyond surface dose: subcutaneous dose escalation underlies TomoTherapy's skin toxicity in breast radiotherapy.

Jiao Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.